Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,900
Closed -$1.51M 99
2025
Q4
$1.51M Buy
+5,900
New +$1.55M 0.2% 41
2025
Q3
Sell
-5,300
Closed -$1.29M 90
2025
Q2
$1.29M Buy
+5,300
New +$1.32M 0.56% 44
2024
Q2
Sell
-3,100
Closed -$1.07M 86
2024
Q1
$1.07M Buy
3,100
+900
+41% +$341K 0.52% 64
2023
Q4
$1.01M Sell
2,200
-200
-8% -$98.6K 0.59% 27
2023
Q3
$1.17M Hold
2,400
0.58% 19
2023
Q2
$1.07M Buy
+2,400
New +$1.21M 0.5% 43
2020
Q2
Sell
-2,900
Closed -$910K 85
2020
Q1
$910K Buy
+2,900
New +$978K 0.62% 13
2017
Q2
Sell
-5,300
Closed -$1.09M 83
2017
Q1
$1.09M Buy
+5,300
New +$1.1M 0.66% 34

Other funds holding HUM

Polianta Ltd's HUM Position: Q1 2026 in Review

Polianta Ltd sold out of Humana (HUM) in Q1 2026, closing a stake of 5,900 shares — an estimated $1.51M sold.

Polianta Ltd first reported a position in HUM in Q1 2017 and held it in 8 quarters. The position peaked at $1.51M in Q4 2025. 780 funds tracked by Wall St. Rank hold HUM as of Q1 2026.

  • Polianta Ltd reported no remaining Humana position as of Q1 2026 after selling out during the quarter.
  • Polianta Ltd sold 5,900 Humana shares in Q1 2026, an estimated $1.51M.
  • Polianta Ltd first reported a position in Humana in Q1 2017 and held it in 8 quarters.
  • Polianta Ltd's Humana position peaked at $1.51M in Q4 2025.
  • 780 funds tracked by Wall St. Rank held Humana as of Q1 2026.

Based on Polianta Ltd's 13F filing for Q1 2026, filed 16 Apr 2026.